Matches in Wikidata for { <http://www.wikidata.org/entity/Q99529682> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q99529682 description "clinical trial" @default.
- Q99529682 description "ensayo clínico" @default.
- Q99529682 description "ensayu clínicu" @default.
- Q99529682 description "klinisch onderzoek" @default.
- Q99529682 description "клінічне випробування" @default.
- Q99529682 description "临床试验" @default.
- Q99529682 name "Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies" @default.
- Q99529682 name "Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies" @default.
- Q99529682 type Item @default.
- Q99529682 label "Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies" @default.
- Q99529682 label "Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies" @default.
- Q99529682 prefLabel "Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies" @default.
- Q99529682 prefLabel "Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies" @default.
- Q99529682 P1050 Q99529682-B02E9CDA-91CA-41AA-B975-94EAC25BE047 @default.
- Q99529682 P1132 Q99529682-46909223-71D8-47BB-B159-4428D5ECA35B @default.
- Q99529682 P1476 Q99529682-BDB0954D-9FE9-4E45-B3AE-BB2F07BF0C9C @default.
- Q99529682 P17 Q99529682-FCEB5A4C-ED0E-4CA2-897A-6A0793BEEB0D @default.
- Q99529682 P2899 Q99529682-935F2084-508F-493E-8DBC-8350FEFA9850 @default.
- Q99529682 P3098 Q99529682-AA75954C-809F-4485-848E-93C485E82AAD @default.
- Q99529682 P31 Q99529682-DFA1B73D-169E-4410-BE57-0186B1590637 @default.
- Q99529682 P4844 Q99529682-1D0F8829-4851-414D-98A5-0595DC413CDC @default.
- Q99529682 P4844 Q99529682-2CEDE841-7E23-4EFC-B175-441B5CA2EDAF @default.
- Q99529682 P580 Q99529682-196738E6-F1D6-4F6D-BEB5-51ABD404C872 @default.
- Q99529682 P582 Q99529682-69658A39-D6CC-4056-B9F1-EB84D1BF52C8 @default.
- Q99529682 P6099 Q99529682-A3C4D949-74BA-4423-B593-AF40A942FFE6 @default.
- Q99529682 P6153 Q99529682-5731E8CA-3998-4740-BBDD-35C38F273D80 @default.
- Q99529682 P8005 Q99529682-5E75CCF2-E0C0-4724-9059-D3C4D5C554E6 @default.
- Q99529682 P8363 Q99529682-0F330659-951D-4655-951D-84950CB3BB82 @default.
- Q99529682 P1050 Q33525 @default.
- Q99529682 P1132 "+92" @default.
- Q99529682 P1476 "A Phase 1/1b Study of Sitravatinib in Combination With Nivolumab and Ipilimumab in Patients With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies" @default.
- Q99529682 P17 Q30 @default.
- Q99529682 P2899 "+18" @default.
- Q99529682 P3098 "NCT04518046" @default.
- Q99529682 P31 Q30612 @default.
- Q99529682 P4844 Q2459042 @default.
- Q99529682 P4844 Q7041828 @default.
- Q99529682 P580 "2020-08-11T00:00:00Z" @default.
- Q99529682 P582 "2023-07-01T00:00:00Z" @default.
- Q99529682 P6099 Q5452194 @default.
- Q99529682 P6153 Q7896459 @default.
- Q99529682 P8005 Q76649708 @default.
- Q99529682 P8363 Q78089383 @default.